(1) registration requirements to establish the eligibility of a pharmacy to participate in the program;

(2) a formulary that includes all eligible prescription drugs approved by the federal Food and Drug Administration;

(3) standards and procedures for: (a) verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board; (b) handling of a donated eligible prescription drug, including: (i) acceptance; (ii) identification, including redundant criteria for verification; (iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements; (iv) safe storage; (v) security; (vi) inspection; (vii) transfer; and (viii) dispensing; (c) a pharmacist or licensed pharmacy technician working in or consulting with a participating eligible donor; (d) disposition of a donated prescription drug that is a controlled substance; (e) record keeping regarding: (i) the eligible donor that donated each prescription drug; (ii) the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and (iii) the dispensing or disposition of a prescription drug; (f) determining the status of a medically indigent individual; (g) labeling requirements to: (i) ensure compliance with patient privacy laws relating to: (A) an individual who receives an eligible prescription drug; and (B) patient information that may appear on a donated prescription drug; (ii) clearly identify an eligible prescription drug dispensed under the program; and (iii) communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and (h) ensuring compliance with the requirements of this part;

(a) verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board;

(b) handling of a donated eligible prescription drug, including: (i) acceptance; (ii) identification, including redundant criteria for verification; (iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements; (iv) safe storage; (v) security; (vi) inspection; (vii) transfer; and (viii) dispensing;

(i) acceptance;

(ii) identification, including redundant criteria for verification;

(iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements;

(iv) safe storage;

(v) security;

(vi) inspection;

(vii) transfer; and

(viii) dispensing;

(c) a pharmacist or licensed pharmacy technician working in or consulting with a participating eligible donor;

(d) disposition of a donated prescription drug that is a controlled substance;

(e) record keeping regarding: (i) the eligible donor that donated each prescription drug; (ii) the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and (iii) the dispensing or disposition of a prescription drug;

(i) the eligible donor that donated each prescription drug;

(ii) the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and

(iii) the dispensing or disposition of a prescription drug;

(f) determining the status of a medically indigent individual;

(g) labeling requirements to: (i) ensure compliance with patient privacy laws relating to: (A) an individual who receives an eligible prescription drug; and (B) patient information that may appear on a donated prescription drug; (ii) clearly identify an eligible prescription drug dispensed under the program; and (iii) communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and

(i) ensure compliance with patient privacy laws relating to: (A) an individual who receives an eligible prescription drug; and (B) patient information that may appear on a donated prescription drug;

(A) an individual who receives an eligible prescription drug; and

(B) patient information that may appear on a donated prescription drug;

(ii) clearly identify an eligible prescription drug dispensed under the program; and

(iii) communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and

(h) ensuring compliance with the requirements of this part;

(4) a process for seeking input from: (a) the Department of Health, created in Section 26-1-4, to establish program standards and procedures for assisted living facilities and nursing care facilities; and (b) the Division of Substance Abuse and Mental Health, created in Section 62A-15-103, to establish program standards and procedures for mental health and substance abuse clients; and

(a) the Department of Health, created in Section 26-1-4, to establish program standards and procedures for assisted living facilities and nursing care facilities; and

(b) the Division of Substance Abuse and Mental Health, created in Section 62A-15-103, to establish program standards and procedures for mental health and substance abuse clients; and

(5) the creation of a special training program that a pharmacist and a licensed pharmacy technician at an eligible pharmacy must complete before participating in the program.